Details for 2018182695
Up to date per 02.04.2026
Actions
Details for 2018182695
Granted/Registered
European Patent
23.01.2019 A
30.12.2020 B1
21.01.2014
US
201461929795 P
04.02.2014
EP
14153887
04.02.2014
EP
14153880
03.09.2014
EP
14183324
02.10.2014
EP
14187429
15.12.2014
US
201462091668 P
A61K 31/4015 20060101AFI20200206BHEP
Owner
Janssen Pharmaceutica NVTurnhoutseweg 30 2340 BeerseBE
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
KLEIN, Brian, D.c/o: Neuroadjuvants, Inc. 417 Wakara Way, Suite 3111 Salt Lake City, Utah UT 84108US
LAVREYSEN, Hildec/o: Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE
PYPE, Stefan, Maria, Christiaanc/o: Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE
TWYMAN, Roy, E.c/o: Janssen Research & Development, LLC 920 US Route 202, PO BOX 300 Raritan, New Jersey NJ 08869US
VAN OSSELAER, Nancy, Eulalie, Sylvainc/o: Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE
WHITE, H., Stevenc/o: Neuroadjuvants, Inc. 417 Wakara Way, Suite 3111 Salt Lake City, Utah UT 84108US
CEUSTERS, Marc Andréc/o: Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE
CID-NÚÑEZ, José, Mariac/o: Janssen-Cilag, S.A., Edificio Johnson & Johnson, Paseo de las Doce Estrellas, 5-7, 5° planta, Campo de las Naciones 28042 MadridES
TRABANCO-SUÁREZ, Andrés, Avelinoc/o: Janssen-Cilag, S.A., Edificio Johnson & Johnson, Paseo de las Doce Estrellas, 5-7, 5° planta, Campo de las Naciones 28042 MadridES
BONE, Roger, Francisc/o: London Innovation Centre 1, Chapel Place London, W1G DBGGB
Information about Fees